Centiva Capital, LP Ab Cellera Biologics Inc. Transaction History
Centiva Capital, LP
- $3.13 Billion
- Q1 2025
A detailed history of Centiva Capital, LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 46,621 shares of ABCL stock, worth $94,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,621
Previous 62,899
25.88%
Holding current value
$94,174
Previous $184,000
44.02%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ABCL
# of Institutions
151Shares Held
121MCall Options Held
156KPut Options Held
346K-
Baker Bros. Advisors LP New York, NY27.5MShares$55.6 Million0.73% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$27 Million0.01% of portfolio
-
Baillie Gifford & CO11.2MShares$22.6 Million0.02% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$21.5 Million0.03% of portfolio
-
Ubs Group Ag5.08MShares$10.3 Million0.0% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $576M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...